NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/28/2025
Back to search
Official data from USPTO
LYMPHOMA RESEARCH FOUNDATION
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LYMPHOMA RESEARCH FOUNDATION
ST13
US500000076497467Class
35, 36, 41
Filing
76497467
Registration
2950493
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
08/19/2025
Trademark type
Word
Nice classes
35, 36, 41
Filing date
03/14/2003
Registration date
05/10/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
2001-09-00
First use in commerce
2001-09-00
Drawing code
1
Owner type
99
Owner location
New York, NY
Examiner
ERVIN, INGA
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
L. F. (pessoa física)
Representatives
Elizabeth A. Jaffe Golenbock Eiseman Assor Bell & Peskoe LLP
Technical classification
Nice Classes
Class 35Class 36Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
PROMOTING PUBLIC AWARENESS OF THE NEED FOR RESEARCH AND TREATMENT IN THE FIELD OF LYMPHOMA
Class 36
FUNDING RESEARCH IN THE FIELD OF LYMPHOMA; AND CHARITABLE FUNDRAISING IN THE FIELD OF LYMPHOMA
Class 41
EDUCATIONAL SERVICESORGANIZING AND CONDUCTING CONFERENCESSEMINARSSYMPOSIASUPPORT GROUPSWORKSHOPS IN THE FIELD OF LYMPHOMA
Publications
History of USPTO decisions and trademark events.
31 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
07/28/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/28/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/02/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/02/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/02/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/02/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/02/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
03/06/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05/10/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/03/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/03/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/03/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/02/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
09/22/2014
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/10/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/10/2011
ES8R
TEAS SECTION 8 RECEIVED
04/21/2011
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
05/10/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/31/2005
ALIE
ASSIGNED TO LIE
01/28/2005
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
01/26/2005
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/13/2005
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/02/2004
PAPER RECEIVED
12/02/2004
CNRT
NON-FINAL ACTION MAILED
06/02/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/27/2004
PAPER RECEIVED
02/27/2004
CNRT
NON-FINAL ACTION MAILED
09/16/2003
DOCK
ASSIGNED TO EXAMINER
09/15/2003
Continuous trademark protection
Get notified about every new filing that threatens LYMPHOMA RESEARCH FOUNDATION or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.